Medicinal Product Shortages – update – 23 March 2022

Notice type: Advisory

Date: 23/03/2022


Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Movymia 20mcg/80mcl Solution for Injection - EU/1/16/1161/001-002
  • Relpax 40mg Film Coated Tablets - PA23055/002/002
  • RoActemra 162mg Solution for Injection in Pre Filled Syringe - EU/1/08/492/007
  • Saline Steri-Neb 0.9%w/v Nebuliser Solution - PA1986/087/001


The following shortages have been resolved and supply has resumed to the Irish market:

  • Clexane 6,000 IU (60mg) /0.6ml Solution for Injection in Pre Filled Syringes - PA0540/097/006
  • Effentora Tablets 100mcg Buccal Tablet - EU/1/08/441/001
  • Flecainide 50mg Tablets - PA1986/050/001
  • MST Continus 5mg Prolonged Release Tablets - PA1688/004/001
  • Telfast 120mg Film Coated Tablets - PA23180/003/002
  • ViATIM, Suspension and Solution for Suspension for Injection in Pre Filled Syringe. Hepatitis A (inactivated, adsorbed) and Typhoid Polysaccharide Vaccine - PA2131/014/001


Please see the shortages section of the HPRA website for further information.

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.


« Back